- Home
- ESLA vs SWIN Comparison
ESLA vs SWIN Comparison
Compare ESLA & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- SWIN
- Stock Information
- Founded
- ESLA 2021
- SWIN 2017
- Country
- ESLA United States
- SWIN Hong Kong
- Employees
- ESLA N/A
- SWIN N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- SWIN
- Sector
- ESLA Health Care
- SWIN
- Exchange
- ESLA Nasdaq
- SWIN Nasdaq
- Market Cap
- ESLA 35.5M
- SWIN 214.1M
- IPO Year
- ESLA N/A
- SWIN 2023
- Fundamental
- Price
- ESLA $0.88
- SWIN $3.93
- Analyst Decision
- ESLA Strong Buy
- SWIN
- Analyst Count
- ESLA 1
- SWIN 0
- Target Price
- ESLA $16.00
- SWIN N/A
- AVG Volume (30 Days)
- ESLA 18.4K
- SWIN 208.1K
- Earning Date
- ESLA 08-20-2025
- SWIN 08-21-2025
- Dividend Yield
- ESLA N/A
- SWIN N/A
- EPS Growth
- ESLA N/A
- SWIN N/A
- EPS
- ESLA N/A
- SWIN N/A
- Revenue
- ESLA N/A
- SWIN $3,316,000.00
- Revenue This Year
- ESLA N/A
- SWIN $29.79
- Revenue Next Year
- ESLA N/A
- SWIN $54.60
- P/E Ratio
- ESLA N/A
- SWIN N/A
- Revenue Growth
- ESLA N/A
- SWIN N/A
- 52 Week Low
- ESLA $0.63
- SWIN $1.16
- 52 Week High
- ESLA $1.97
- SWIN $4.40
- Technical
- Relative Strength Index (RSI)
- ESLA 46.61
- SWIN 62.05
- Support Level
- ESLA $0.83
- SWIN $3.70
- Resistance Level
- ESLA $0.95
- SWIN $3.99
- Average True Range (ATR)
- ESLA 0.07
- SWIN 0.35
- MACD
- ESLA 0.01
- SWIN -0.03
- Stochastic Oscillator
- ESLA 55.88
- SWIN 93.02
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.